This mutation has minimal effects on CoV replication in transformed cells but reduces viral load, leads to enhanced IFN production, and strongly attenuates both murine hepatitis virus (MHV) and SARS-CoV in mouse models of infection (7, 18, 21, 22). This evidence concerns the gene IFNA1 and infection.